TRANSCEND THERAPEUTICS INC (CIK: 0001020910) EDGAR, Information, Filings... CompaniesBIO.Com

TRANSCEND THERAPEUTICS INC

Mailing address
738 MAIN STREET, SUITE 431, WALTHAM, Delaware, 02451
Phone
6173741200
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

TRANSCEND THERAPEUTICS INC (CIK: 0001020910) is an American company incorporated in the state of Massachusetts. Head office is located at 738 MAIN STREET, SUITE 431, WALTHAM, Massachusetts, 02451. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). TRANSCEND THERAPEUTICS INC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TRANSCEND THERAPEUTICS INC

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001012870-99-001868 ( Act) Size: KB	Jun-09-1999	000-22383 99643049
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-99-002581 ( Act) Size: KB	May-12-1999	000-22383 99618605
10-K405/A	Document	Acc-no: 0000927016-99-001784 ( Act) Size: KB	May-04-1999	000-22383 99609692
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0000927016-99-001568 ( Act) Size: KB	Apr-21-1999	000-22383 99597892
10-K405	Document	Acc-no: 0000927016-99-001259 ( Act) Size: KB	Mar-31-1999	000-22383 99583095
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000888002-99-000157 ( Act) Size: KB	Feb-16-1999	005-52371 99541758
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950128-99-000412 ( Act) Size: KB	Feb-09-1999	005-52371 99526282
8-K	Document	Current report filing Acc-no: 0000950135-99-000057 ( Act) Size: KB	Jan-08-1999	000-22383 99502662
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-98-005936 ( Act) Size: KB	Nov-16-1998	000-22383 98750922
8-K	Document	Current report filing Acc-no: 0000950135-98-004895 ( Act) Size: KB	Aug-21-1998	000-22383 98696091
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-98-004759 ( Act) Size: KB	Aug-14-1998	000-22383 98688008
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950135-98-003399 ( Act) Size: KB	May-15-1998	000-22383 98625349
DEF 14A	Document	Definitive proxy statements Acc-no: 0000950135-98-002844 ( Act) Size: KB	Apr-30-1998	000-22383 98606887
10-K405	Document	Acc-no: 0000950135-98-002073 ( Act) Size: KB	Mar-31-1998	000-22383 98581487
8-K	Document	Current report filing Acc-no: 0000950135-98-001807 ( Act) Size: KB	Mar-25-1998	000-22383 98572911
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902561-98-000073 ( Act) Size: KB	Feb-27-1998	005-52371 98551809
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950135-98-001066 ( Act) Size: KB	Feb-17-1998	005-52371 98542181
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950131-98-001127 ( Act) Size: KB	Feb-17-1998	005-52371 98542197
5	Document	Annual statement of changes in beneficial ownership of securities Acc-no: 0000902561-98-000061 ( Act) Size: 0 KB	Feb-17-1998	000-22383 98541551
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000888002-98-000093 ( Act) Size: KB	Feb-17-1998	005-52371 98541381

Recent 20 filings. View all TRANSCEND THERAPEUTICS INC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

TRANSCEND THERAPEUTICS INC overview
TRANSCEND THERAPEUTICS INC job
TRANSCEND THERAPEUTICS INC stock
TRANSCEND THERAPEUTICS INC ownership
TRANSCEND THERAPEUTICS INC CEO
TRANSCEND THERAPEUTICS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.